BioCentury
DATA GRAPHICS | Finance

Data Byte: new entrants to IPO queue as NASDAQ tops $16B raised from biotechs

October 24, 2020 2:23 AM UTC

Even with the U.S. election less than two weeks away, biotechs are continuing to push ahead with IPOs. October has seen at least six new entrants to the IPO queue, and Flagship-backed Foghorn became the latest to make its public debut after market close on Thursday. 

Expected post-election volatility may well push the pause button on IPOs, but even so, biotech IPOs have already had a banner year, with 71 companies raising a collective $16 billion on NASDAQ alone, through Oct. 23. ...